Significant changes seen in physiologic and inhaler use metrics in the 14 days before exacerbation

Study reveals no significant differences by race/ethnicity or sex

Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction

Increased risk for consumption seen during periods of rising estradiol levels

In landmark analyses, lower risk did not persist beyond five years of survival

Prevalence of high-grade dysplasia or cancer was 0.4 percent in low-risk group of patients

Benlysta is the first and only approved autoinjector biologic for both systemic lupus erythematosus and lupus nephritis

Three-tiered agnostic approach is proposed based on diagnostic yield and practical considerations

High triglyceride-glucose index significantly associated with faster cognitive decline in the MCI-Alzheimer disease subgroup

Increased muscle echo intensity effectively identifies insulin resistance and impaired insulin sensitivity